Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
A randomized controlled two-armed phase III trial for gastric cancer patients with peritoneal
dissemination. Randomization between gastrectomy + cytoreductive surgery + HIPEC
(experimental arm) and palliative systemic chemotherapy (standard arm).
Phase:
Phase 3
Details
Lead Sponsor:
The Netherlands Cancer Institute
Collaborators:
Catharina Ziekenhuis Eindhoven Erasmus Medical Center St. Antonius Hospital UMC Utrecht University Medical Center Groningen